Scott Thomas Smith
EVP & Chief Financial Officer · Ascendis Pharma A/S
- 2026
- Jun 2, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Scott Thomas Smith files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Flemming Steen Jensen - $4.64M in ASND purchases and sales in the last 12 months
- Mads Bodenhoff - $811K in ASND purchases and sales in the last 12 months
- Jean Jacques Bienaime - $699K in ASND purchases and sales in the last 12 months
- Lars Holtug - $62K in ASND purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Scott Thomas Smith?
Scott Thomas Smith is a corporate insider, tracked as EVP & Chief Financial Officer of Ascendis Pharma A/S (ASND). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Scott Thomas Smith last file a Form 4?
The most recent primary Form 4 on record is dated 2 June 2026, one of 2 filings going back to 2026.
Has Scott Thomas Smith been buying or selling stock?
Recorded transactions: 2 open-market purchases ($78K) and 0 open-market sales across all tracked filings.
